Debates and Roundtables

COVID-19 Impact on Management of Hematologic Malignancies


A panel of experts sat down with Oncology Learning Network to discuss the impact of the current pandemic on the management of patients with hematologic malignancies, focusing on what is practical and needed for hematologists/oncologists as they are taking care of patients that may be dealing with or are at risk for COVID-19 in their practice.

The panel is moderated by John Leonard, MD, Senior Associate Dean at Weill Cornell Medicine and Professor of Hematology/Oncology focusing primarily in lymphoma at Weill Cornell at NewYork‑Presbyterian Hospital.

Joining Dr Leonard are David Steensma, MD, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA; Sagar Lonial, MD, FACP, Winship Cancer Institute of Emory University, Atlanta, GA; Krishna Komanduri, MD, Sylvester Comprehensive Cancer Center at the University of Miami, FL; Jessica Altman, MD, Feinberg School of Medicine at Northwestern University, Chicago, IL; and Michael Angarone, DO, Feinberg School of Medicine at Northwestern University.

Read the transcript here.

4 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Stay in the know.
OncNet Newsletter